DeepMed Research

Charité - Universitätsmedizin Berlin

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Private

Established: 1710-01-01

Employees: 10K

Market Cap: -

Website: http://www.charite.de

Clinical Trials

Clinical Nutrition Concept for Hospitalized Patients With Malnutrition

Not Applicable

Completed

Conditions: Malnutrition

Interventions: Behavioral: evidence based clinical nutrition concept
Behavioral: care as usual

First Posted Date: 2008-05-07

Last Posted Date: 2016-03-08

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 10242

Registration Number: NCT00673530

Locations: 🇩🇪
Evangelische und Johanniter Kliniken, Duisburg, Germany
🇩🇪
Kliniken Südliche Weinstraße Landau, Bad Bergzabern, Germany
🇩🇪
Städtisches Klinikum Ansbach, Ansbach, Germany

and more 1 locations

Hydrocortisone for Prevention of Septic Shock

Phase 3

Completed

Conditions: Severe Sepsis

Interventions: Drug: Hydrocortisone
Drug: Placebo

First Posted Date: 2008-05-01

Last Posted Date: 2013-09-27

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 380

Registration Number: NCT00670254

Locations: 🇩🇪
Zentralklinik Bad Berka GmbH, Zentrum für Anaesthesie, Intensivtherapie und Notfallmedizin, Bad Berka, Germany
🇩🇪
HELIOS Klinikum Bad Saarow; Zentrum für Anaesthesiologie, Intensivmedizin, Notfallmedizin und Schmerztherapie, Bad Saarow, Germany
🇩🇪
Vivantes Klinikum Hellersdorf, Klinik fuer Anaesthesie, operative Intensivmedizin und Schmerztherapie, Berlin, Germany

and more 27 locations

Stimulation of Gastric Slow Waves With Acupuncture at St36 and Pe6 - a Randomized Single-blind Controlled Trial

Not Applicable

Completed

Conditions: Acupuncture

Interventions: Procedure: verum acupuncture
Procedure: sham acupuncture

First Posted Date: 2008-03-14

Last Posted Date: 2012-07-10

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 65

Registration Number: NCT00636012

Locations: 🇩🇪
Charité University Medical Center, Berlin, Germany

Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)

Phase 3

Conditions: Elevated Lipoprotein(a) Levels

Interventions: Drug: Nicotinic acid (niacin)
Drug: Placebo

First Posted Date: 2008-03-12

Last Posted Date: 2009-08-04

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 150

Registration Number: NCT00633698

Locations: 🇩🇪
Institute of Social Medicine, Epidemiology and Health Economics, Berlin, Germany

Narrow Band Versus Conventional Endoscopic Imaging for Screening Colonoscopy

Not Applicable

Completed

Conditions: Adenoma

Interventions: Device: Olympus NBI colonoscope 180 HDTV narrow band imaging (diagnostic test)

First Posted Date: 2008-03-12

Last Posted Date: 2008-03-12

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 1250

Registration Number: NCT00633620

Locations: 🇩🇪
Charité University Hospitals, Campus Virchow Hospital, Berlin, Germany

Prevention of the Age-Related Cognitive Impairment by Exercise and Mental Activity - Berlin Bleibt Fit

Phase 3

Conditions: Cognition
Mood

Interventions: Behavioral: Exercise
Behavioral: Mental activity

First Posted Date: 2008-03-05

Last Posted Date: 2008-03-12

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 252

Registration Number: NCT00629174

Locations: 🇩🇪
Section Sports Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
🇩🇪
Department of Psychiatry, Berlin, Germany

Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Device: bare metal stent
Device: Cypher-Stent (Implantation of a sirolimus-eluting stent)

First Posted Date: 2008-03-04

Last Posted Date: 2008-03-04

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 958

Registration Number: NCT00627900

Locations: 🇩🇪
Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Berlin, Germany

Sildenafil for Treatment of Digital Ulcers in Patients With Systemic Sclerosis

Phase 2

Completed

Conditions: Active Digital Ulcers

Interventions: Drug: Sildenafil therapy

First Posted Date: 2008-02-27

Last Posted Date: 2009-01-07

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 17

Registration Number: NCT00624273

Locations: 🇩🇪
Riemekasten, PD Dr. med., Berlin, Germany

Flupirtine as Oral Treatment in Multiple Sclerosis

Phase 2

Terminated

Conditions: Relapsing Remitting Multiple Sclerosis

Interventions: Drug: Placebo
Drug: Flupirtine

First Posted Date: 2008-02-26

Last Posted Date: 2018-03-20

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 30

Registration Number: NCT00623415

Locations: 🇩🇪
NeuroCure Clinical Research Center, Charité Berlin, Berlin, Germany
🇩🇪
Carl-Thiem-Clinic Cottbus, Cottbus, Germany
🇩🇪
University of Ulm, Department of Neurology, Ulm, Germany

and more 1 locations

Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis

Phase 2

Terminated

Conditions: Systemic Sclerosis

Interventions: Drug: iloprost low dose
Drug: iloprost
Drug: iloprost therapy up to 2 ng/kg x min

First Posted Date: 2008-02-25

Last Posted Date: 2008-02-25

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 50

Registration Number: NCT00622687

Locations: 🇩🇪
Charrité Universitätsmedizin, Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy